The effect of curcumin on neurological complications of diabetes and HbA1c levels

Not Applicable

• Conditions: diabetic individuals with neuropathic disorders.; Type 2 diabetes mellitus with neurological complications; E11.4

• Registration Number: IRCT20130811014330N6
• Lead Sponsor: Mashhad University of Medical Sciences,vice chancellor for research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Diabetes mellitus with neuropathy (gloves and socks)
Age range of 70-18 years,
at least five years with illness
The same type of medication used,
Taking oral medicine

Exclusion Criteria

Age over 70 years and under 18 years
Taking insulin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c. Timepoint: before and after using curcumin. Method of measurement: electrophoresis.

Secondary Outcome Measures

Name	Time	Method
2. The lab profile includes Lip a, BUN, U / A, Cr, FBS, TG, TC, HDL, LDL. Timepoint: Before and after using curcumin. Method of measurement: Spectrophotometry using an autoanalyzer.